URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

John Bisognano

Concepts (327)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of pubs Most recent pub Pubs by all authors Concept score Why?
Hypertension
34
1998
301
14.110
Why?
Antihypertensive Agents
21
1998
79
8.520
Why?
Baroreflex
9
2006
22
5.710
Why?
Electric Stimulation Therapy
9
2006
29
5.100
Why?
Blood Pressure
13
2004
467
3.980
Why?
Carotid Sinus
6
2006
11
2.470
Why?
Drug Resistance
6
2006
102
1.750
Why?
Heart Failure
5
1996
367
1.740
Why?
Diuretics
4
2006
31
1.490
Why?
Humans
57
1993
36274
1.460
Why?
Fumarates
3
2008
19
1.410
Why?
Amides
3
2008
35
1.390
Why?
Angiotensin-Converting Enzyme Inhibitors
6
1998
48
1.370
Why?
Treatment Outcome
12
2004
2615
1.340
Why?
Electrodes, Implanted
6
2006
57
1.280
Why?
Renin-Angiotensin System
3
1999
18
1.170
Why?
Electrocardiography
5
2003
773
1.150
Why?
Amlodipine
2
2004
6
1.000
Why?
Hospitalization
2
2007
399
0.980
Why?
Life Style
2
2011
85
0.940
Why?
Angiotensin Receptor Antagonists
2
1998
8
0.910
Why?
Emergency Treatment
2
1999
34
0.860
Why?
Tobacco Use Cessation Products
1
2012
3
0.860
Why?
Acute Coronary Syndrome
1
2012
10
0.840
Why?
Female
22
1997
19838
0.830
Why?
Sympathetic Nervous System
2
2006
116
0.830
Why?
Male
24
1997
19675
0.830
Why?
Heart Transplantation
2
1999
71
0.820
Why?
Renin
2
2008
58
0.820
Why?
Plant Preparations
1
2011
2
0.810
Why?
Retrospective Studies
9
2004
2267
0.800
Why?
Middle Aged
17
1997
9837
0.800
Why?
Patient Care
1
2012
40
0.800
Why?
Heart Neoplasms
2
2008
21
0.790
Why?
Implantable Neurostimulators
1
2011
2
0.790
Why?
Dietary Supplements
1
2011
44
0.770
Why?
Smoking Cessation
1
2012
80
0.770
Why?
Community Health Services
1
2012
77
0.770
Why?
Sympathectomy
1
2011
21
0.770
Why?
Myocardial Ischemia
2
2007
118
0.770
Why?
Adrenergic beta-Antagonists
2
2007
174
0.760
Why?
Lymphoma, Large B-Cell, Diffuse
2
2008
78
0.730
Why?
Continuous Positive Airway Pressure
1
2010
6
0.720
Why?
Endocarditis
1
2010
11
0.720
Why?
Mitral Valve Insufficiency
1
2010
24
0.710
Why?
Arrhythmias, Cardiac
1
2012
246
0.710
Why?
Hypertension, Pregnancy-Induced
1
2009
4
0.710
Why?
Sleep Apnea, Obstructive
1
2010
14
0.710
Why?
Mitral Valve
1
2010
39
0.710
Why?
Catheter Ablation
1
2011
73
0.700
Why?
Hemodynamics
2
2004
272
0.700
Why?
Thromboembolism
1
2010
41
0.700
Why?
Calcium Channel Blockers
2
2007
67
0.700
Why?
Pressoreceptors
1
2009
10
0.680
Why?
Quality of Health Care
1
2012
209
0.680
Why?
Erythema Multiforme
1
2009
3
0.670
Why?
Metoprolol
1
2009
10
0.670
Why?
Circadian Rhythm
1
2009
84
0.660
Why?
Music
1
2009
20
0.660
Why?
Staphylococcus aureus
1
2010
108
0.650
Why?
Diterpenes, Kaurane
1
2008
1
0.650
Why?
Comorbidity
3
2003
380
0.640
Why?
Pregnancy Outcome
1
2009
137
0.640
Why?
Sweetening Agents
1
2008
16
0.640
Why?
Aged
13
1998
7269
0.630
Why?
Smoking
1
2012
399
0.620
Why?
Deglutition Disorders
1
2008
21
0.620
Why?
Heart Diseases
1
2009
142
0.600
Why?
Trans Fatty Acids
1
2007
2
0.600
Why?
Echocardiography
5
1998
228
0.600
Why?
Natriuretic Peptide, Brain
1
2007
11
0.590
Why?
Blood Urea Nitrogen
1
2007
43
0.590
Why?
Drugs, Generic
1
2007
10
0.590
Why?
Cardiac Output, Low
1
2007
16
0.590
Why?
Kidney
1
2011
586
0.590
Why?
Energy Intake
1
2007
57
0.580
Why?
Vascular Diseases
1
2007
70
0.560
Why?
Patient Care Planning
1
2007
71
0.560
Why?
Protein Precursors
1
2007
84
0.560
Why?
Receptors, Endothelin
1
2006
15
0.550
Why?
Health Policy
1
2007
78
0.550
Why?
Coronary Disease
2
2003
258
0.540
Why?
Ailanthus
1
2005
1
0.530
Why?
Leukoaraiosis
1
2005
1
0.530
Why?
Hospital Costs
1
2006
35
0.530
Why?
Myocarditis
1
2005
14
0.530
Why?
Geriatric Assessment
1
2007
158
0.520
Why?
Cardiovascular Diseases
2
2004
277
0.520
Why?
Coronary Vasospasm
1
2005
8
0.510
Why?
Myocardium
3
1996
294
0.510
Why?
Peptide Fragments
1
2007
282
0.510
Why?
Tetrazoles
1
2004
9
0.500
Why?
Valine
1
2004
32
0.500
Why?
Brain Ischemia
1
2005
86
0.480
Why?
Follow-Up Studies
4
2003
1855
0.470
Why?
Emergency Service, Hospital
1
2006
213
0.450
Why?
Drug Therapy, Combination
4
1998
382
0.450
Why?
Stroke
1
2005
134
0.440
Why?
Acute Disease
4
1999
586
0.430
Why?
Myocardial Infarction
2
2003
660
0.430
Why?
Predictive Value of Tests
3
2008
606
0.430
Why?
Adult
11
1997
11351
0.430
Why?
Time Factors
4
2007
3182
0.420
Why?
New York
3
2007
1305
0.410
Why?
Aged, 80 and over
5
1998
2529
0.390
Why?
Prognosis
3
2007
1083
0.370
Why?
Receptors, Adrenergic, beta-1
1
2000
1
0.370
Why?
Randomized Controlled Trials as Topic
3
2004
411
0.360
Why?
Parvovirus B19, Human
1
1999
5
0.350
Why?
Parvoviridae Infections
1
1999
11
0.350
Why?
Europe
2
2007
80
0.340
Why?
Erythropoietin
1
1999
28
0.340
Why?
Proto-Oncogene Proteins c-bcl-2
1
2000
116
0.340
Why?
Animals
7
2000
16093
0.340
Why?
Hypertension, Malignant
1
1999
6
0.340
Why?
Stroke Volume
3
2007
154
0.330
Why?
Immunocompromised Host
1
1999
83
0.330
Why?
Heart
1
2000
236
0.320
Why?
Ventricular Outflow Obstruction
1
1998
11
0.320
Why?
Tricuspid Valve
1
1998
17
0.320
Why?
Exercise
2
2008
182
0.310
Why?
Blood Pressure Monitoring, Ambulatory
2
2007
13
0.310
Why?
Subclavian Artery
1
1997
26
0.310
Why?
Survival Rate
2
2007
618
0.300
Why?
Risk Factors
3
2008
2345
0.300
Why?
Odds Ratio
2
2003
315
0.290
Why?
Double-Blind Method
2
2008
992
0.290
Why?
Biological Markers
3
2000
560
0.280
Why?
United States
3
2007
2688
0.280
Why?
Logistic Models
2
2008
611
0.270
Why?
Michigan
2
2003
19
0.260
Why?
Erythrocytes
2
1993
337
0.260
Why?
Echocardiography, Transesophageal
2
1998
52
0.250
Why?
Length of Stay
2
2006
287
0.250
Why?
Angiotensin II Type 1 Receptor Blockers
2
2004
9
0.250
Why?
Clinical Trials as Topic
2
2007
671
0.240
Why?
Protons
2
1993
79
0.230
Why?
Hydroxides
1
1993
25
0.230
Why?
Labetalol
2
1999
4
0.220
Why?
Emergencies
2
1999
81
0.220
Why?
Feasibility Studies
2
2004
202
0.210
Why?
Electric Power Supplies
1
2012
10
0.210
Why?
Social Marketing
1
2012
9
0.210
Why?
Education
1
2012
40
0.200
Why?
Breathing Exercises
1
2011
3
0.200
Why?
Confidence Intervals
1
2012
165
0.200
Why?
Program Development
1
2012
81
0.190
Why?
Cohort Studies
2
2009
969
0.190
Why?
Cooperative Behavior
1
2012
101
0.190
Why?
Program Evaluation
1
2012
206
0.190
Why?
Registries
1
2012
223
0.190
Why?
Severity of Illness Index
2
1999
922
0.190
Why?
Ventricular Function, Left
1
2011
95
0.180
Why?
Practice Guidelines as Topic
2
2010
302
0.180
Why?
Nafcillin
1
2010
2
0.180
Why?
Rhinitis, Allergic, Perennial
1
2010
5
0.180
Why?
Motivation
1
2012
156
0.180
Why?
Retinal Vessels
1
2010
36
0.180
Why?
Echocardiography, Doppler, Color
1
2010
16
0.180
Why?
Eclampsia
1
2009
7
0.180
Why?
Maternal Mortality
1
2009
9
0.180
Why?
Blood Pressure Determination
1
2009
21
0.180
Why?
Carotid Body
1
2009
10
0.180
Why?
Meta-Analysis as Topic
1
2010
36
0.180
Why?
Pre-Eclampsia
1
2009
26
0.170
Why?
Hypersensitivity
1
2010
44
0.170
Why?
Incidence
1
2012
685
0.170
Why?
Markov Chains
1
2009
40
0.170
Why?
Health Promotion
1
2012
151
0.170
Why?
Diastole
1
2009
26
0.170
Why?
Monitoring, Physiologic
1
2009
100
0.170
Why?
Systole
1
2009
39
0.170
Why?
Prenatal Care
1
2009
67
0.170
Why?
Heart Atria
1
2009
68
0.170
Why?
Takotsubo Cardiomyopathy
1
2009
3
0.170
Why?
Hydroxyzine
1
2009
3
0.170
Why?
Adrenal Cortex Neoplasms
1
2009
12
0.170
Why?
Histamine H1 Antagonists
1
2009
16
0.170
Why?
Coronary Angiography
2
2005
85
0.170
Why?
Periodicity
1
2009
41
0.170
Why?
Pheochromocytoma
1
2009
37
0.170
Why?
Hypotension
1
2009
47
0.160
Why?
Treatment Failure
1
2009
128
0.160
Why?
Esophageal Neoplasms
1
2009
75
0.160
Why?
Drug Evaluation, Preclinical
1
2008
76
0.160
Why?
Equipment Design
1
2009
248
0.160
Why?
Chi-Square Distribution
1
2009
344
0.160
Why?
Carotid Arteries
1
2009
100
0.150
Why?
Posture
1
2008
110
0.150
Why?
Placebos
1
2008
178
0.150
Why?
Proportional Hazards Models
1
2009
450
0.150
Why?
Kidney Diseases
1
2010
170
0.150
Why?
Health Status Indicators
1
2008
107
0.150
Why?
Diet, Fat-Restricted
1
2007
4
0.150
Why?
Diet, Sodium-Restricted
1
2007
13
0.150
Why?
Combined Modality Therapy
1
2009
486
0.150
Why?
Minoxidil
1
2007
2
0.150
Why?
Body Weight
1
2008
327
0.150
Why?
Hospitals, Special
1
2007
7
0.150
Why?
Chlorthalidone
1
2007
4
0.150
Why?
Drug Costs
1
2007
25
0.150
Why?
Sodium Chloride Symporter Inhibitors
1
2007
10
0.150
Why?
Evidence-Based Medicine
1
2009
202
0.140
Why?
Electric Stimulation
1
2007
224
0.140
Why?
Risk Reduction Behavior
1
2007
39
0.140
Why?
Receptors, Cell Surface
1
2008
203
0.140
Why?
Ambulatory Care Facilities
1
2007
33
0.140
Why?
Patient Readmission
1
2007
39
0.140
Why?
Creatinine
1
2007
127
0.140
Why?
Video Games
1
2007
24
0.140
Why?
Diet
1
2008
204
0.140
Why?
Diabetes Complications
1
2007
66
0.140
Why?
Patient Admission
1
2007
85
0.140
Why?
Risk
1
2007
368
0.140
Why?
Captopril
1
2006
12
0.140
Why?
Forecasting
1
2007
177
0.140
Why?
Metabolic Syndrome X
1
2007
60
0.140
Why?
Vasoconstriction
1
2006
41
0.140
Why?
Multivariate Analysis
1
2008
541
0.140
Why?
Clonidine
1
2006
34
0.140
Why?
Asthma
1
2010
317
0.130
Why?
Obesity
1
2010
339
0.130
Why?
Patient-Centered Care
1
2007
76
0.130
Why?
Heart Rate
1
2008
461
0.130
Why?
Treatment Refusal
1
2006
43
0.130
Why?
Anti-Bacterial Agents
1
2010
437
0.130
Why?
Patient Compliance
1
2007
174
0.130
Why?
Magnetic Resonance Imaging
2
2008
991
0.130
Why?
Nitroglycerin
1
2005
19
0.130
Why?
Nerve Fibers, Myelinated
1
2005
38
0.130
Why?
Risk Assessment
1
2009
884
0.130
Why?
Young Adult
1
2009
1059
0.120
Why?
Isoproterenol
1
2004
74
0.120
Why?
Vasodilator Agents
1
2005
75
0.120
Why?
Adrenergic beta-Agonists
1
2004
51
0.120
Why?
Prevalence
1
2007
562
0.120
Why?
Disease Models, Animal
1
2009
956
0.120
Why?
4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid
2
1993
12
0.120
Why?
Emergency Medical Services
1
2006
134
0.120
Why?
Graft Rejection
1
2005
143
0.120
Why?
Dementia
1
2005
102
0.120
Why?
Transplantation, Homologous
1
2005
276
0.120
Why?
Pregnancy
1
2009
1966
0.120
Why?
Fatal Outcome
2
1997
104
0.120
Why?
Energy Metabolism
1
2004
137
0.120
Why?
Troponin I
1
2003
5
0.120
Why?
Chlorides
2
1993
123
0.110
Why?
Creatine Kinase
1
2003
53
0.110
Why?
Patient Education as Topic
1
2005
214
0.110
Why?
Cardiovascular Agents
1
2003
22
0.110
Why?
Syndrome
1
2003
208
0.110
Why?
Cerebral Cortex
1
2005
248
0.110
Why?
Sex Distribution
1
2003
160
0.110
Why?
Age Distribution
1
2003
221
0.110
Why?
Genetic Predisposition to Disease
1
2005
331
0.110
Why?
Disease Progression
1
2005
521
0.110
Why?
Reference Values
1
2003
439
0.100
Why?
Regression Analysis
1
2003
527
0.100
Why?
Rats
1
2009
4289
0.090
Why?
Diagnosis, Differential
2
1997
874
0.090
Why?
bcl-2-Associated X Protein
1
2000
56
0.090
Why?
Fenoldopam
1
1999
1
0.080
Why?
Nitroprusside
1
1999
32
0.080
Why?
Injections, Intravenous
1
1999
131
0.080
Why?
Drug Monitoring
1
1999
41
0.080
Why?
Adolescent
1
2008
4766
0.080
Why?
Infusions, Intravenous
1
1999
143
0.080
Why?
Aortitis
1
1997
1
0.080
Why?
Dyspnea
1
1997
13
0.080
Why?
Aortic Aneurysm, Thoracic
1
1997
16
0.080
Why?
Aneurysm, Infected
1
1997
11
0.080
Why?
Cough
1
1997
22
0.080
Why?
Proto-Oncogene Proteins
1
2000
289
0.080
Why?
Mice, Transgenic
1
2000
749
0.070
Why?
Brain
1
2005
1214
0.070
Why?
Heterogeneous-Nuclear Ribonucleoprotein D
1
1996
2
0.070
Why?
Streptococcus pyogenes
1
1997
102
0.070
Why?
Gene Expression
1
2000
751
0.070
Why?
Receptors, Adrenergic, beta
1
1996
67
0.070
Why?
Sodium
2
1993
298
0.070
Why?
Membrane Potentials
2
1993
340
0.070
Why?
Potassium
2
1993
304
0.070
Why?
Streptococcal Infections
1
1997
171
0.070
Why?
Chronic Disease
1
1997
522
0.060
Why?
Gramicidin
1
1994
2
0.060
Why?
Valinomycin
1
1994
15
0.060
Why?
RNA-Binding Proteins
1
1996
130
0.060
Why?
Postoperative Complications
1
1999
733
0.060
Why?
Apoptosis
1
2000
823
0.060
Why?
Ethoxzolamide
1
1993
2
0.060
Why?
4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic Acid
1
1993
9
0.060
Why?
Carbocyanines
1
1993
20
0.060
Why?
Body Water
1
1993
33
0.060
Why?
Sucrose
1
1993
85
0.060
Why?
Saline Solution, Hypertonic
1
1993
28
0.060
Why?
Benzothiazoles
1
1993
54
0.060
Why?
Osmolar Concentration
1
1993
154
0.060
Why?
Indicators and Reagents
1
1993
113
0.060
Why?
Hemoglobins
1
1993
95
0.060
Why?
Scattering, Radiation
1
1993
76
0.060
Why?
Light
1
1993
159
0.050
Why?
Gene Expression Regulation
1
1996
888
0.050
Why?
Sleep Apnea Syndromes
1
2010
16
0.040
Why?
Esophagogastric Junction
1
2009
9
0.040
Why?
Hypertension, Pulmonary
1
2010
29
0.040
Why?
Endoscopy, Gastrointestinal
1
2009
26
0.040
Why?
Quality-Adjusted Life Years
1
2009
53
0.040
Why?
Sex Characteristics
1
2010
138
0.040
Why?
Catecholamines
1
2009
79
0.040
Why?
RNA, Messenger
1
1996
1863
0.040
Why?
Cost-Benefit Analysis
1
2009
215
0.040
Why?
Mice
1
2000
6111
0.040
Why?
Sensitivity and Specificity
1
2009
905
0.030
Why?
Tomography, X-Ray Computed
1
2009
759
0.030
Why?
Oxygen Consumption
1
2004
204
0.030
Why?
Polyribosomes
1
1996
21
0.020
Why?
Muscle, Smooth
1
1996
99
0.020
Why?
Ultraviolet Rays
1
1996
199
0.020
Why?
Intracellular Fluid
1
1994
42
0.020
Why?
DNA Primers
1
1996
403
0.020
Why?
GTP-Binding Proteins
1
1996
141
0.020
Why?
Cell Membrane Permeability
1
1994
101
0.020
Why?
Ion Transport
1
1994
70
0.020
Why?
Recombinant Proteins
1
1996
723
0.010
Why?
Base Sequence
1
1996
1683
0.010
Why?
Molecular Sequence Data
1
1996
1988
0.010
Why?
Signal Transduction
1
1996
1567
0.010
Why?

Visualizations


Bisognano's Networks

Concepts
_
Co-Authors
_
Similar People
_
Same Department